An observational study in Uterine Diseases, sponsored by Yasser S Mostafa, MD. Completed at 1 site in Egypt. Open to female participants aged 30 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-10-26.
Sponsored by Yasser S Mostafa, MD · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Epidural anesthesia is a widely used method for pain relief which is useful in various settings. Identification of needle entry into the epidural space (EDS) is performed most using a loss of resistance (LOR) technique, which was described in 1921 by Sicard and Forestier, and has remained largely unchanged since. Hysterectomy operations anesthesia and analgesia rely heavily on proper needle placement technique. A noninvasive approach to confirm the correct position of the epidural needle prior to injection of local anesthetics into the epidural space, would thus be beneficial. Ultrasound (US) is a noninvasive approach increasingly used in anesthesia practice. The use of color flow Doppler (CFD) may further aid in defining the epidural space. The aim of current study is to detect and confirm site of epidural catheter in hysterectomy by using color flow doppler ultrasonography.
This study will be performed in the Fayoum University hospital. The study design will be prospective study. A detailed informed consent will be signed by the eligible patients .
female patients who undergoing an ultrasound guided for hysterectomy will be included in this review. The ultrasound guided epidural will be used in those in which an anticipated technical difficult landmark epidural space localization will be expected. These included those patients with diagnosis of obesity, defined as Body Mass Index (BMI) ≥35 kg/m2, and lumbar scoliosis, as well as those with poorly defined surface lumbar bone anatomy.
Demographic data, intervertebral level of insertion, dermatome level, and failure rate of epidural needle placement using CFD will be noted for each patient. Operation will be obtained via spinal epidural technique.
Sterile preparation and dropping of the area will be followed by placement of a curvilinear ultrasound transducer in a sterile sheath. The ultrasound will be used to identify the interspinous space. The epidural needle will be guided with the use of ultrasound direction by the use of an out of plane technique.
A two-hand technique will be used to manipulate the needle and ultrasound probe.
A 17-G Tuohy needle (Braun Medical, Inc., Melsungen,AG, Germany) will be advanced until loss of resistance to normal saline will be attained.
Confirmation of the epidural space with the use of CFD will be then obtained after injection of up to 10 mL of normal saline through the epidural needle.
A 21-G epidural catheter (B. Braun Medical, Inc.) will be then threaded into the epidural space.
A 22G, 50mm needle (SONOTAP,Pajunk,Geisingen,Germany will be then advanced until CSF is obtained.
Use of intrathecal local anesthetic will be then used as a bolus in the spinal space.
After loss of resistance to normal saline, the CFD function will be turned on to examine flow through the epidural needle tip.
The ultrasound probe was positioned in the transverse axis slightly below the epidural needle but still in the interspinous space .
Two-dimensional (2D) ultrasound images will be initially obtained after making adjustments on the ultrasound system.
These include an appropriate scanning depth (6-12 cm), using the "penetration" or "general" frequency range and adjusting the gain or the time gate compensation to improve image resolution.
The CFD function will be then turned on and then the window will be adjusted to be centered over the area of interest. The authors will adjust color baseline to enhance the qualitative depiction of flow. The authors also increased color gain to amplify the appearance of flow changes. The color gain was adjusted to a level that provided the best image while avoiding the display of random color speckles. The orientation and tilt of the ultrasound probe will be essential for optimal visualization of the CFD pattern.
The best views were obtained while the probe was tilted upwards, parallel to the lumbar spinous process orientation, in order to avoid shadow interference cast by the spinous process bony structure. This maneuver will optimize the 2D view by minimizing the shadowing caused by bony structures.
The color scale will be adjusted to maximize color flow while avoiding excessive aliasing.
The best images will be best seen with a color scale on the range of 12-20 without needing to adjust the baseline.
Sample size was calculated using G-Power©️ software version 3.1.7 (Institute of experimental psychology, Heinrich Heine University, Dusseldorf, Germany).Minimal sample size of patients was (60) patients. Effect size 0.47 Depending on previous research results. Two tailed type I error 0.05 and power of 80%.
Statistical analysis will be performed using SPSS version 24.0 (IBM, Armonk, NY, USA). Data will be tested for normality using the Kolmogorov-Smirnov test. Continuous variables are presented as mean ± standard deviation (SD) or median (interquartile range) as appropriate and categorical variables are presented as number of patients (%). Parametric continuous variables will be analyzed by unpaired t-test and non-parametric continuous variables will be analyzed by Mann-Whitney U test. For categorical variables, the Chi-square (X2) test or Fisher's exact test will be used as appropriate. Two-tailed p values of 0.05 will be considered statistically significant.
73 studies on the registry are indexed under Uterine Diseases; 9 are open to participants now.
This study's enrollment of 60 is below the median of 135 across 13 observational studies indexed under Uterine Diseases.
Browse Uterine Diseases studies →Yasser S Mostafa, MD is the lead sponsor of 4 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Primary gynecology and obstetric care clinic in Fayoum university hospital
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
After placement of the epidural catheter, parasagittal and transverse views with CFD will be obtained to identify location of the catheter within the epidural space. Two levels above and below the insertion site will be used to locate the epidural catheter.
Drug: Normal Saline Flush · Device: Doppler
Five milliliters of sterile saline will be administered as a flush through the needle while recording the color flow doppler images. The same procedure will be repeated with a slow injection of 5 mL of saline. The speed of injection will not be standardized.
Also known as: 0.9% isotonic normal saline
All color flow Doppler images will be performed with a Phillips CX50 ultrasound machine using a 5.0 MHz a low frequency curvilinear US probe. A two-dimensional transverse interspinous view was used to visualize the posterior complex (ligamentum flavum, epidural space and dura). After loss of resistance to normal saline, the color flow Doppler function will be turned on to examine flow through the epidural needle tip. The ultrasound probe was positioned in the transverse axis slightly below the epidural needle but still in the interspinous space .
Also known as: Color flow Doppler
Visualization of flow relative to the interspace insertion level by color flow Doppler
Yes or no
Time frame: 1 minute after insertion of epidural catheter
Level of epidural catheter insertion
From Lumbar level 1 to 5
Time frame: 1 minute after insertion of epidural catheter
Verbal numerical rating scale
0-10 where 0: no pain and 10:worst pain
Time frame: 8 hours postoperatively
Duration of epidural analgesia
in hours
Time frame: First 24 hours postoperatively.
Incidence of patchy or asymmetric block
Yes or no
Time frame: 15 minutes after insertion of epidural catheter
Maximum upper sensory block to ice as charted by the nurse
Dermatomal level thoracic level 10 up to umbilicus
Time frame: 15 minutes after insertion of epidural catheter
Intervertebral level at which the epidural catheter is inserted
From Lumbar level 2-3 or 3-4
Time frame: 1 minute after insertion of epidural catheter
Age
in years
Time frame: 1 hour preoperatively
Height
in meter
Time frame: 1 hour preoperatively
Weight
in kilogram
Time frame: 1 hour preoperatively
Body mass index
kilogram/square meter
Time frame: 1 hour preoperatively
Duration of surgery
in hours
Time frame: Up to 5 hours
Plan to share: No
Ran from Apr 2023 to primary completion in Feb 2024, 10 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Yasser S Mostafa, MD